Copyright Reports & Markets. All rights reserved.

Global Oral Mesalazine Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Oral Mesalazine by Type
    • 1.3.1 Overview: Global Oral Mesalazine Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Oral Mesalazine Consumption Value Market Share by Type in 2025
    • 1.3.3 Tablets
    • 1.3.4 Capsules
    • 1.3.5 Granule
  • 1.4 Global Oral Mesalazine Market by Application
    • 1.4.1 Overview: Global Oral Mesalazine Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Ulcerative Colitis
    • 1.4.3 Crohn's Disease
    • 1.4.4 Inflammatory Bowel Disease
    • 1.4.5 Others
  • 1.5 Global Oral Mesalazine Market Size & Forecast
  • 1.6 Global Oral Mesalazine Market Size and Forecast by Region
    • 1.6.1 Global Oral Mesalazine Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Oral Mesalazine Market Size by Region, (2021-2032)
    • 1.6.3 North America Oral Mesalazine Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Oral Mesalazine Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Oral Mesalazine Market Size and Prospect (2021-2032)
    • 1.6.6 South America Oral Mesalazine Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Oral Mesalazine Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 AbbVie
    • 2.1.1 AbbVie Details
    • 2.1.2 AbbVie Major Business
    • 2.1.3 AbbVie Oral Mesalazine Product and Solutions
    • 2.1.4 AbbVie Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AbbVie Recent Developments and Future Plans
  • 2.2 Shire
    • 2.2.1 Shire Details
    • 2.2.2 Shire Major Business
    • 2.2.3 Shire Oral Mesalazine Product and Solutions
    • 2.2.4 Shire Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Shire Recent Developments and Future Plans
  • 2.3 Salix Pharmaceuticals
    • 2.3.1 Salix Pharmaceuticals Details
    • 2.3.2 Salix Pharmaceuticals Major Business
    • 2.3.3 Salix Pharmaceuticals Oral Mesalazine Product and Solutions
    • 2.3.4 Salix Pharmaceuticals Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Salix Pharmaceuticals Recent Developments and Future Plans
  • 2.4 Ferring Global
    • 2.4.1 Ferring Global Details
    • 2.4.2 Ferring Global Major Business
    • 2.4.3 Ferring Global Oral Mesalazine Product and Solutions
    • 2.4.4 Ferring Global Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Ferring Global Recent Developments and Future Plans
  • 2.5 Teva Pharmaceutical Industries
    • 2.5.1 Teva Pharmaceutical Industries Details
    • 2.5.2 Teva Pharmaceutical Industries Major Business
    • 2.5.3 Teva Pharmaceutical Industries Oral Mesalazine Product and Solutions
    • 2.5.4 Teva Pharmaceutical Industries Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
  • 2.6 Morningside Healthcare
    • 2.6.1 Morningside Healthcare Details
    • 2.6.2 Morningside Healthcare Major Business
    • 2.6.3 Morningside Healthcare Oral Mesalazine Product and Solutions
    • 2.6.4 Morningside Healthcare Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Morningside Healthcare Recent Developments and Future Plans
  • 2.7 Dr. Falk Pharma UK
    • 2.7.1 Dr. Falk Pharma UK Details
    • 2.7.2 Dr. Falk Pharma UK Major Business
    • 2.7.3 Dr. Falk Pharma UK Oral Mesalazine Product and Solutions
    • 2.7.4 Dr. Falk Pharma UK Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Dr. Falk Pharma UK Recent Developments and Future Plans
  • 2.8 Nogra Pharma Limited
    • 2.8.1 Nogra Pharma Limited Details
    • 2.8.2 Nogra Pharma Limited Major Business
    • 2.8.3 Nogra Pharma Limited Oral Mesalazine Product and Solutions
    • 2.8.4 Nogra Pharma Limited Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Nogra Pharma Limited Recent Developments and Future Plans
  • 2.9 Tillotts Pharma
    • 2.9.1 Tillotts Pharma Details
    • 2.9.2 Tillotts Pharma Major Business
    • 2.9.3 Tillotts Pharma Oral Mesalazine Product and Solutions
    • 2.9.4 Tillotts Pharma Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Tillotts Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Oral Mesalazine Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Oral Mesalazine by Company Revenue
    • 3.2.2 Top 3 Oral Mesalazine Players Market Share in 2025
    • 3.2.3 Top 6 Oral Mesalazine Players Market Share in 2025
  • 3.3 Oral Mesalazine Market: Overall Company Footprint Analysis
    • 3.3.1 Oral Mesalazine Market: Region Footprint
    • 3.3.2 Oral Mesalazine Market: Company Product Type Footprint
    • 3.3.3 Oral Mesalazine Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Oral Mesalazine Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Oral Mesalazine Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Oral Mesalazine Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Oral Mesalazine Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Oral Mesalazine Consumption Value by Type (2021-2032)
  • 6.2 North America Oral Mesalazine Market Size by Application (2021-2032)
  • 6.3 North America Oral Mesalazine Market Size by Country
    • 6.3.1 North America Oral Mesalazine Consumption Value by Country (2021-2032)
    • 6.3.2 United States Oral Mesalazine Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Oral Mesalazine Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Oral Mesalazine Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Oral Mesalazine Consumption Value by Type (2021-2032)
  • 7.2 Europe Oral Mesalazine Consumption Value by Application (2021-2032)
  • 7.3 Europe Oral Mesalazine Market Size by Country
    • 7.3.1 Europe Oral Mesalazine Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Oral Mesalazine Market Size and Forecast (2021-2032)
    • 7.3.3 France Oral Mesalazine Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Oral Mesalazine Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Oral Mesalazine Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Oral Mesalazine Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Oral Mesalazine Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Oral Mesalazine Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Oral Mesalazine Market Size by Region
    • 8.3.1 Asia-Pacific Oral Mesalazine Consumption Value by Region (2021-2032)
    • 8.3.2 China Oral Mesalazine Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Oral Mesalazine Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Oral Mesalazine Market Size and Forecast (2021-2032)
    • 8.3.5 India Oral Mesalazine Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Oral Mesalazine Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Oral Mesalazine Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Oral Mesalazine Consumption Value by Type (2021-2032)
  • 9.2 South America Oral Mesalazine Consumption Value by Application (2021-2032)
  • 9.3 South America Oral Mesalazine Market Size by Country
    • 9.3.1 South America Oral Mesalazine Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Oral Mesalazine Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Oral Mesalazine Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Oral Mesalazine Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Oral Mesalazine Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Oral Mesalazine Market Size by Country
    • 10.3.1 Middle East & Africa Oral Mesalazine Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Oral Mesalazine Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Oral Mesalazine Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Oral Mesalazine Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Oral Mesalazine Market Drivers
  • 11.2 Oral Mesalazine Market Restraints
  • 11.3 Oral Mesalazine Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Oral Mesalazine Industry Chain
  • 12.2 Oral Mesalazine Upstream Analysis
  • 12.3 Oral Mesalazine Midstream Analysis
  • 12.4 Oral Mesalazine Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Oral Mesalazine market size was valued at US$ 99 million in 2025 and is forecast to a readjusted size of US$ 127 million by 2032 with a CAGR of 3.6% during review period.
    Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn"s disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Oral Mesalazine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Oral Mesalazine market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Oral Mesalazine market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Oral Mesalazine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Oral Mesalazine market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Oral Mesalazine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Oral Mesalazine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Shire, Salix Pharmaceuticals, Ferring Global, Teva Pharmaceutical Industries, Morningside Healthcare, Dr. Falk Pharma UK, Nogra Pharma Limited, Tillotts Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Oral Mesalazine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Tablets
    Capsules
    Granule
    Market segment by Application
    Ulcerative Colitis
    Crohn's Disease
    Inflammatory Bowel Disease
    Others
    Market segment by players, this report covers
    AbbVie
    Shire
    Salix Pharmaceuticals
    Ferring Global
    Teva Pharmaceutical Industries
    Morningside Healthcare
    Dr. Falk Pharma UK
    Nogra Pharma Limited
    Tillotts Pharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Oral Mesalazine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Oral Mesalazine, with revenue, gross margin, and global market share of Oral Mesalazine from 2021 to 2026.
    Chapter 3, the Oral Mesalazine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Oral Mesalazine market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Mesalazine.
    Chapter 13, to describe Oral Mesalazine research findings and conclusion.

    Buy now